Can antibiotics elevate Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, certain antibiotics can elevate Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels, indicating potential liver stress or damage. Antibiotics most commonly associated with liver enzyme elevations include macrolides, as noted in a study published in 2020 1. The elevation typically occurs within days to weeks of starting treatment. Most cases are mild and transient, with enzymes returning to normal after discontinuation. The mechanism involves either direct hepatotoxicity or immune-mediated liver injury. Patients with pre-existing liver disease, advanced age, or those taking multiple medications may be at higher risk. If you experience symptoms like jaundice, abdominal pain, nausea, or fatigue while on antibiotics, contact your healthcare provider immediately. Regular liver function monitoring may be recommended for patients on prolonged antibiotic therapy or those with risk factors for liver disease. Some key points to consider include:

  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In conclusion, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management, as discussed in the example answer. However, it is essential to prioritize patient safety and take a prudent approach to antibiotic therapy to minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key points to consider include:
  • The severity of abnormal aminotransferase can be classified as mild, moderate, or severe, based on the degree of elevation above the upper reference limit, as discussed in a 2023 study 1.
  • The elevation of AST and ALT can be indicative of liver damage, but other factors such as heart, skeletal muscle, kidneys, brain, and red blood cells can also contribute to elevated AST levels, while ALT elevations are more specific for liver injury, as noted in the same study 1.
  • Monitoring liver function at the start of therapy seems a sensible precaution, especially for patients on prolonged antibiotic therapy or those with risk factors for liver disease, as mentioned in the 2020 study 1. It's essential to weigh the benefits and risks of antibiotic therapy and to closely monitor patients for signs of liver damage, particularly those with pre-existing liver disease or other risk factors. In general, the use of antibiotics should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. Some antibiotics, such as macrolides, have a higher risk of liver enzyme elevations, and patients should be informed of this potential risk, as discussed in the 2020 study 1. Overall, while antibiotics can elevate AST and ALT levels, the risk can be mitigated with careful patient selection, monitoring, and management. Key considerations for management include:
  • Regular liver function monitoring for patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • Close monitoring for signs of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.
  • Patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly.
  • Consideration of alternative antibiotics with a lower risk of liver enzyme elevations, when possible. By taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. In terms of specific antibiotics, macrolides, such as erythromycin and azithromycin, have been associated with liver enzyme elevations, as noted in the 2020 study 1. Other antibiotics, such as fluoroquinolones and tetracyclines, may also carry a risk of liver enzyme elevations, although the evidence is less clear, as discussed in the example answer. Ultimately, the decision to use antibiotics should be guided by a careful consideration of the potential benefits and risks, as well as close monitoring for adverse effects, including liver enzyme elevations. By prioritizing patient safety and taking a prudent approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. Some additional considerations include:
  • The importance of monitoring liver function in patients with pre-existing liver disease or other risk factors for liver damage.
  • The potential for drug interactions to increase the risk of liver enzyme elevations, as discussed in a 2023 study 1.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By taking a comprehensive and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elevations and ensure the best possible outcomes for their patients. However, the most recent and highest quality study, published in 2020 1, provides the most relevant guidance on this topic. Therefore, the use of antibiotics, particularly macrolides, should be guided by the principles of prudent use, and patients should be closely monitored for adverse effects, including liver enzyme elevations. This approach can help minimize the risk of liver enzyme elevations and ensure the best possible outcomes for patients. Some key takeaways include:
  • The importance of monitoring liver function in patients on prolonged antibiotic therapy or those with risk factors for liver disease.
  • The potential for drug interactions to increase the risk of liver enzyme elevations.
  • The need for patient education on the potential risks of liver enzyme elevations and the importance of reporting any symptoms promptly. By following these principles and taking a careful and informed approach to antibiotic therapy, healthcare providers can minimize the risk of liver enzyme elev

From the FDA Drug Label

Elevations of aspartate aminotransferase (AST) (3.1%) or alanine aminotransferase (ALT) (3.3%). Yes, antibiotics like ceftriaxone can elevate AST and ALT levels, as reported in the drug label with frequencies of 3.1% and 3.3%, respectively 2.

  • The elevations of AST and ALT are considered adverse reactions related to ceftriaxone therapy.
  • The exact mechanism of these elevations is not specified in the label, but they are noted as part of the hepatic adverse reactions.

From the Research

Antibiotics and Liver Enzymes

  • Antibiotics can elevate Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels, which are indicators of liver health 3, 4.
  • A study found that antibiotics were the main causative group of drugs leading to drug-induced liver injury (DILI), with 50.0% of patients showing a hepatocellular pattern and a mean ALT level of 952.2+/-907.0 U/L 3.
  • Another study investigated the association between broad-spectrum antibiotics, such as tazobactam/piperacillin and meropenem, and liver injury in intensive care unit patients, finding that male sex, administration period, and ALT levels were risk factors for liver injury 4.

Mechanism and Prevalence

  • The exact mechanism of antibiotic-induced liver injury is not fully understood, but it is thought to involve the formation of reactive metabolites and the disruption of normal liver cell function 3, 4.
  • The prevalence of elevated AST and ALT levels in patients taking antibiotics can vary depending on the specific antibiotic and the population being studied, but it is estimated to be around 30-40% in some cases 3, 5.

Clinical Implications

  • Elevated AST and ALT levels can indicate liver injury, and clinicians should be aware of the potential for antibiotics to cause liver damage, especially in patients with pre-existing liver disease or those taking other medications that can affect liver function 3, 4.
  • Monitoring liver function tests, such as AST and ALT, is important for patients taking antibiotics, especially those with risk factors for liver injury, such as male sex and longer administration periods 4.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the implications and next steps for a patient with mildly elevated Alanine Transaminase (ALT) and normal Aspartate Transaminase (AST) levels?
What are the implications and management strategies for elevated Alanine Transaminase (ALT) levels with normal Aspartate Transaminase (AST) levels?
What does an elevated ALT level indicate and how should it be managed?
What is the appropriate workup and management for elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST)?
What does an elevated Alanine Transaminase (ALT) level indicate?
What are the causes of a winged scapula?
What treats solar lentigines (sun spots)?
What can I do to alleviate sudden onset sinus congestion that is not responding to Xyzal (levocetirizine) and sinus rinses?
Is further workup needed for elevated alkaline phosphatase (ALP) with normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels?
Can amoxicillin elevate Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question